tiprankstipranks
Doctors gain confidence in new Alzheimer’s blood tests, Bloomberg reports
The Fly

Doctors gain confidence in new Alzheimer’s blood tests, Bloomberg reports

Blood-test manufacturers are preparing to change the way Alzheimer’s disease is diagnosed with a nearing blockbuster treatment for millions of Americans, Bloomberg’s Robert Langreth reports. Even doctors who were initially concerned about tests for Alzheimer’s are gaining confidence that products from Quest Diagnostics (DGX), Quanterix (QTRX) and C2N Diagnostics can aid in determining which patients may qualify for treatment with the experimental drug lecanemab, set to be approved next year. Reference Link

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on DGX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles